Literature DB >> 16368521

Tissue factor initiated blood coagulation.

Keith Gomez1, John H McVey.   

Abstract

Tissue factor (TF) is the cellular receptor and cofactor for blood coagulation factor (F) VII. Exposure of flowing blood to cells that express TF leads to the initiation of blood coagulation. Blood coagulation is tightly regulated to generate a local fibrin clot at the site of vascular injury without compromising blood flow in the vasculature. This chapter describes the initiation and propagation of the response and how it is ultimately down-regulated to prevent widespread inappropriate blood coagulation.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16368521     DOI： 10.2741/1888

Source DB:  PubMed          Journal:  Front Biosci        ISSN： 1093-4715


  11 in total

1.  The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.

Authors:  T C Carneiro-Lobo; F Schaffner; J Disse; H Ostergaard; I M B Francischetti; R Q Monteiro; W Ruf
Journal:  J Thromb Haemost       Date:  2012-09       Impact factor: 5.824

2.  Expression patterns and action analysis of genes associated with blood coagulation responses during rat liver regeneration.

Authors:  Li-Feng Zhao; Wei-Min Zhang; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

3.  The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation.

Authors:  Kevin G Phillips; Angela M Lee; Garth W Tormoen; Rachel A Rigg; Anand Kolatkar; Madelyn Luttgen; Kelly Bethel; Lyudmila Bazhenova; Peter Kuhn; Paul Newton; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2014-11-19       Impact factor: 4.249

Review 4.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model.

Authors:  T C Carneiro-Lobo; S Konig; D E Machado; L E Nasciutti; M F Forni; I M B Francischetti; M C Sogayar; R Q Monteiro
Journal:  J Thromb Haemost       Date:  2009-07-17       Impact factor: 5.824

6.  Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation.

Authors:  Christoph Reinhardt; Marie-Luise von Brühl; Davit Manukyan; Lenka Grahl; Michael Lorenz; Berid Altmann; Silke Dlugai; Sonja Hess; Ildiko Konrad; Lena Orschiedt; Nigel Mackman; Lloyd Ruddock; Steffen Massberg; Bernd Engelmann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

7.  Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Authors:  Vipul C Chitalia; Sowmya Shivanna; Jordi Martorell; Mercedes Balcells; Irene Bosch; Kumaran Kolandaivelu; Elazer R Edelman
Journal:  Circulation       Date:  2012-12-25       Impact factor: 29.690

Review 8.  The role of saliva in tick feeding.

Authors:  Ivo M B Francischetti; Anderson Sa-Nunes; Ben J Mans; Isabel M Santos; Jose M C Ribeiro
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  Modeling and simulation of procoagulant circulating tumor cells in flow.

Authors:  Angela M Lee; Garth W Tormoen; Eva Kanso; Owen J T McCarty; Paul K Newton
Journal:  Front Oncol       Date:  2012-09-14       Impact factor: 6.244

10.  Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells.

Authors:  Yang Zhao; Daohai Zhang; Sheng Wang; Li Tao; Aiyun Wang; Wenxing Chen; Zhijie Zhu; Shizhong Zheng; Xiang Gao; Yin Lu
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.